Use of antigen combination in preparation of kit for detecting related autoantibodies of lung cancer, and corresponding kit and detection method
An autoantibody and detection method technology, applied in kits and detection, antigen combination in the field of preparing kits for lung cancer-related autoantibody detection, can solve high false positives, insufficient detection sensitivity, and increase the workload of follow-up monitoring in the later period and economic burden to achieve reliable results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] This example specifically illustrates the kit for combined detection of lung cancer-related autoantibodies that can be used to assist in the early screening and diagnosis of lung cancer and the corresponding detection method.
[0054] The kit provided in this example is prepared according to the principle of indirect enzyme-linked immunoassay, specifically: the antigenic protein corresponding to the autoantibody related to lung cancer is connected to the solid-phase carrier, and the autoantibody in the blood sample is combined with it to form a solid-phase carrier during detection. Phase antigen-test autoantibody complex, and then use enzyme-labeled secondary antibody (enzyme-labeled antibody) to combine with the autoantibody in the solid-phase antigen-test autoantibody complex to form a solid-phase antigen-test autoantibody-enzyme label The secondary antibody complex, and then measure the absorbance after adding the substrate to determine the level of the autoantibody t...
Embodiment 2
[0119] In this embodiment, serum samples of 148 early lung cancer patients (lung cancer group) and 142 healthy people (control group) were collected. All patients with lung cancer were diagnosed with early stage lung cancer (in situ, stage I and stage II) by CT examination with nodules less than 20mm. The serum of lung cancer patients was collected before receiving any radiotherapy and chemotherapy. The serum of healthy people came from healthy people without any malignant tumor-related diseases.
[0120] The kit and detection method of Example 1 were used to detect the levels of lung cancer-related autoantibodies in the sera of 148 lung cancer patients and 142 healthy people, respectively, and the detection results of the lung cancer-related autoantibodies in the control group and the lung cancer group were respectively obtained. Use simulated annealing to explore the cut-off value (Cut-off value) of each lung cancer-related autoantibody level. If it is higher than this value...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


